Figure 1

Figure 2

Accuracy and loss data for both training and testing (day10) for day 20 cell models_ Maximum (green) and minimum (red) values signalled for each cell model_
| Training | 4603c27 | IMR90c01 | IMR90-4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day | ID (Diff.) | ID (Prol.) | Accuracy | Loss | ID (Diff.) | ID (Prol.) | Accuracy | Loss | ID (Diff.) | ID (Prol.) | Accuracy | Loss |
| 20 | 1553 | 1514 | 1 | 0 | 1517 | 1519 | 1 | 0.02 | 1552 | 1510 | 0.91 | 0.35 |
| Testing | ||||||||||||
| Day | ID (Diff.) | ID (Prol.) | Accuracy | Loss | ID (Diff.) | ID (Prol.) | Accuracy | Loss | ID (Diff.) | ID (Prol.) | Accuracy | Loss |
| 10 | 1520 | 1564 | 0.78 | 0.65 | 1555 | 2021 | 0.66 | 0.60 | 2020 | 1516 | 0.87 | 0.60 |
| 2012 | 1564 | 0.74 | 0.56 | 2042 | 2021 | 0.57 | 0.77 | 2022 | 1516 | 0.80 | 0.62 | |
| 2041 | 1564 | 0.81 | 0.57 | 2050 | 2021 | 0.64 | 0.90 | 2055 | 1516 | 0.90 | 0.55 | |
| 2044 | 1564 | 0.72 | 0.60 | 2053 | 2021 | 0.64 | 0.57 | 2020 | 1556 | 0.88 | 0.59 | |
| 1520 | 2047 | 0.77 | 0.70 | 1555 | 2048 | 0.67 | 0.63 | 2022 | 1556 | 0.81 | 0.62 | |
| 2012 | 2047 | 0.73 | 0.62 | 2042 | 2048 | 0.57 | 0.79 | 2055 | 1556 | 0.92 | 0.55 | |
| 2041 | 2047 | 0.80 | 0.62 | 2050 | 2048 | 0.65 | 0.92 | 2020 | 2010 | 0.89 | 0.59 | |
| 2044 | 2047 | 0.70 | 0.65 | 2053 | 2048 | 0.65 | 0.60 | 2022 | 2010 | 0.82 | 0.61 | |
| 2055 | 2010 | 0.93 | 0.54 | |||||||||
| 2020 | 2013 | 0.86 | 0.60 | |||||||||
| 2022 | 2013 | 0.79 | 0.62 | |||||||||
| 2055 | 2013 | 0.89 | 0.56 | |||||||||
| 2020 | 2014 | 0.87 | 0.63 | |||||||||
| 2022 | 2014 | 0.80 | 0.65 | |||||||||
| 2055 | 2014 | 0.91 | 0.58 | |||||||||
| Average | 0.76 | 0.62 | 0.63 | 0.72 | 0.86 | 0.59 | ||||||
j_joeb-2019-0018_tab_003_w2aab3b7d245b1b6b1ab2b4b1b1Aa
| Component | Concentration | |
|---|---|---|
| NIM | NPM | |
| Advanced DMEM/F12 : Neurobasal™ | 1:1 | 1:1 |
| B-27™ Supplement | 2 % (v/v) | 2 % (v/v) |
| N-2 Supplement | 1 % (v/v) | 1 % (v/v) |
| GlutaMax™ | 1 % (v/v) | 1 % (v/v) |
| LIF | 10 ng/ml | 10 ng/ml |
| CHIR99021 | 4 μM | 3 μM |
| SB431542 | 3 μM | 2 μM |
| Compound E | 0.1 μM | - |
| BSA | 0.0005 % (w/v) | 0.0005 % (w/v) |
Accuracy and loss data for both training and testing (day 20) for day 20 cell models_ Maximum (green) and minimum (red) values signalled for each cell model_
| Training | 4603c27 | IMR90c01 | IMR90-4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day | ID (Diff.) | ID (Prol.) | Accuracy | Loss | ID (Diff.) | ID (Prol.) | Accuracy | Loss | ID (Diff.) | ID (Prol.) | Accuracy | Loss |
| 20 | 1553 | 1514 | 1 | 0 | 1517 | 1519 | 1 | 0.02 | 1552 | 1510 | 0.91 | 0.35 |
| Testing | ||||||||||||
| Day | ID (Diff.) | ID (Prol.) | Accuracy | Loss | ID (Diff.) | ID (Prol.) | Accuracy | Loss | ID (Diff.) | ID (Prol.) | Accuracy | Loss |
| 20 | 1520 | 1564 | 0.88 | 0.56 | 1555 | 2021 | 0.78 | 0.64 | 2020 | 1516 | 0.87 | 0.50 |
| 2012 | 1564 | 0.87 | 0.77 | 2042 | 2021 | 0.74 | 0.56 | 2022 | 1516 | 0.96 | 0.45 | |
| 2041 | 1564 | 0.94 | 0.22 | 2050 | 2021 | 0.82 | 0.57 | 2055 | 1516 | 0.95 | 0.42 | |
| 2044 | 1564 | 0.97 | 0.15 | 2053 | 2021 | 0.72 | 0.60 | 2020 | 1556 | 0.81 | 0.53 | |
| 1520 | 2047 | 0.86 | 0.55 | 1555 | 2048 | 0.77 | 0.77 | 2022 | 1556 | 0.93 | 0.47 | |
| 2012 | 2047 | 0.85 | 0.79 | 2042 | 2048 | 0.73 | 0.73 | 2055 | 1556 | 0.91 | 0.44 | |
| 2041 | 2047 | 0.93 | 0.16 | 2050 | 2048 | 0.81 | 0.80 | 2020 | 2010 | 0.86 | 0.52 | |
| 2044 | 2047 | 0.97 | 0.82 | 2053 | 2048 | 0.71 | 0.71 | 2022 | 2010 | 0.97 | 0.46 | |
| 2055 | 2010 | 0.96 | 0.43 | |||||||||
| 2020 | 2013 | 0.83 | 0.55 | |||||||||
| 2022 | 2013 | 0.93 | 0.48 | |||||||||
| 2055 | 2013 | 0.92 | 0.46 | |||||||||
| 2020 | 2014 | 0.84 | 0.58 | |||||||||
| 2022 | 2014 | 0.95 | 0.51 | |||||||||
| 2055 | 2014 | 0.93 | 0.48 | |||||||||
| Average | 0.91 | 0.50 | 0.76 | 0.67 | 0.91 | 0.47 | ||||||
j_joeb-2019-0018_tab_004_w2aab3b7d245b1b6b1ab2b4b2b1Aa
| Component | Concentration |
|---|---|
| Astrocyte proliferation medium | |
| Neurobasal™ | |
| FBS | 10 % (v/v) |
| GlutaMax™ | 1.5 % (v/v) |
| Pen/Strep | 0.2 % (v/v) |
| Gentamicin | 0.04 % (v/v) |
| Astro-NDM | |
| DMEM/F12 | |
| Apotransferrin | 0.0095 % (w/v) |
| Ascorbic acid | 300 μM |
| cAMP | 300 nM |
| Glucose monohydrate | 33.3 mM |
| GlutaMax™ | 1 % (v/v) |
| Heparin | 0.0004 % (v/v) |
| HEPES | 5 mM |
| Insulin, human | 0.0025 % (w/v) |
| NaHCO3 | 3 mM |
| Sodium selenite | 30 nM |
| Progesterone | 20 nM |
| Putrescine | 60 nM |
| Pen/Strep | 0.2 % (v/v) |
| Gentamicin | 0.04 % (v/v) |